Back
Keros Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
KROS
Keros Therapeutics
Last Price:
$14.17
Seasonality Move:
4.67%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.26 | Sell |
20-day SMA: | 14.07 | Buy |
50-day SMA: | 12.93 | Buy |
200-day SMA: | 31.6 | Sell |
8-day EMA: | 14.21 | Sell |
20-day EMA: | 14.02 | Buy |
50-day EMA: | 13.81 | Buy |
200-day EMA: | 25.98 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 54.52 | Buy |
Chaikin Money Flow: | 177416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.79 - 14.47) | Buy |
Bollinger Bands (100): | (10.61 - 13.85) | Buy |
Keros Therapeutics Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 14.15 while KROS 8-day simple moving average is 14.26, which is a Sell signal.
-
The stock price of KROS is 14.15 while Keros Therapeutics 20-day SMA is 14.07, which makes it a Buy.
-
Keros Therapeutics 50-day simple moving average is 12.93 while KROS share price is 14.15, making it a Buy technically.
-
KROS stock price is 14.15 and Keros Therapeutics 200-day simple moving average is 31.60, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a SellThe current Keros Therapeutics [KROS] share price is $14.15. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
574.7M
Price in USD:
14.15
Share Volume:
480.3K
Keros Therapeutics 52-Week Range
52-Week High:
72.37
52-Week Low:
9.12
Sell
27
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?The Keros Therapeutics stock price is 14.15 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 14.15 while KROS 8-day exponential moving average is 14.21, which is a Sell signal.
-
The stock price of KROS is 14.15 while Keros Therapeutics 20-day EMA is 14.02, which makes it a Buy.
-
Keros Therapeutics 50-day exponential moving average is 13.81 while KROS share price is 14.15, making it a Buy technically.
-
KROS stock price is 14.15 and Keros Therapeutics 200-day simple moving average is 25.98, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Keros Therapeutics is a Buy
-
Keros Therapeutics Relative Strength Index (RSI) is 54.52, which suggest Keros Therapeutics is overbought
-
The Bollinger Bands (25) for Keros Therapeutics is (13.79 - 14.47), which suggest Keros Therapeutics is a Buy
-
The Bollinger Bands (100) for Keros Therapeutics is (10.61 - 13.85), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.